Corcept Therapeutics (CORT) Operating Expenses (2010 - 2026)
Corcept Therapeutics (CORT) posted Operating Expenses of $214.8 million for Q2 2026, little changed sequentially from $214.5 million in Q1 2026, and up 28.07% YoY from $167.8 million in Q2 2025.
Corcept Therapeutics (CORT) Operating Expenses (2010 - 2026) Analysis & Trends
Corcept Therapeutics has reported Operating Expenses for 17 years, with the latest figure at $214.8 million in Q2 2026.
- Quarterly Operating Expenses rose 28.07% year-over-year to $214.8 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $824.4 million (up 34.24% YoY) and the FY2025 annual result came in at $716.6 million, up 33.18% from the prior year.
- Operating Expenses was little changed at $214.8 million in Q2 2026 per CORT's latest filing, from $214.5 million in the prior quarter.
- Over five years, Operating Expenses peaked at $214.8 million in Q2 2026 and troughed at $66.9 million in Q1 2022.
- A 5-year average of $130.5 million and a median of $122.8 million in 2024 frame the typical range for Operating Expenses.
- The sharpest annual moves came in 2022 and 2024: Operating Expenses climbed 11.91% in 2022, then jumped 50.99% in 2024.
- Over 5 years, Operating Expenses stood at $80.6 million in 2022, then increased by 28.77% to $103.7 million in 2023, then surged by 50.99% to $156.6 million in 2024, then rose by 26.18% to $197.6 million in 2025, then climbed by 8.71% to $214.8 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $214.8 million, $214.5 million, and $197.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Corcept Therapeutics | 12.37 Bn | 12.07 Bn | 252.09 Mn | 214.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 214.85 Mn |
| Mar 31, 2026 | 214.50 Mn |
| Dec 31, 2025 | 197.64 Mn |
| Sep 30, 2025 | 197.42 Mn |
| Jun 30, 2025 | 167.76 Mn |
| Mar 31, 2025 | 153.80 Mn |
| Dec 31, 2024 | 156.63 Mn |
| Sep 30, 2024 | 135.95 Mn |
| Jun 30, 2024 | 128.20 Mn |
| Mar 31, 2024 | 117.31 Mn |
| Dec 31, 2023 | 103.74 Mn |
| Sep 30, 2023 | 92.42 Mn |
| Jun 30, 2023 | 88.13 Mn |
| Mar 31, 2023 | 90.80 Mn |
| Dec 31, 2022 | 80.56 Mn |
| Sep 30, 2022 | 69.79 Mn |
| Jun 30, 2022 | 71.95 Mn |
| Mar 31, 2022 | 66.92 Mn |
| Dec 31, 2021 | 62.16 Mn |
| Sep 30, 2021 | 59.90 Mn |